01 September 2022
It could aid organ repair or lead to the creation of synthetic organs for transplantation.
25 August 2022
The Babraham Research Campus company is due to be acquired by invoX Pharma this year.
25 August 2022
CEO Chris Cargill said the biopharma is making progress on bringing much-needed medicines to patients.
12 August 2022
It has required years of technological development.
11 August 2022
The Granta Park company receives $40m upfront and up to $40m in near-term milestones.
03 August 2022
Its Covid-19 medicine Evusheld is offseting declines in sales of its vaccine.
01 August 2022
Tetris has a licence to sell the first stable liquid ready-to-use glucagon auto-injector pen, Ogluo.
29 July 2022
The Babraham Research Campus company will receive $1m upfront.
28 July 2022
Patients under-served by existing immunotherapies could benefit.
22 July 2022
The GSU will help tackle infectious diseases, including the Covid-19 virus and malaria, using sequencing.
21 July 2022
They will have both an academic and industry supervisor.
21 July 2022
The Innnovate UK grant will fund development of a test showing if patients will respond to doxorubicin.
15 July 2022
They join a group of leading life scientists.
07 July 2022
It follows the award of £2.68million funding.
01 July 2022
Granta Park company arrives with mystery investors rumoured to include Jeff Bezos
01 July 2022
Cambridge microbiome specialist prepares MB097 and MB310 for human testing
17 June 2022
Company says it is pleased with early signs.
16 June 2022
They can be used to test cardiotoxicity in a dish.
10 June 2022
It ‘flips the culprit immune cells into destroying themselves’, explains Prof Mark Evans.
09 June 2022
The cancer genetics pioneer discusses the future of the campus and the importance of biodata.